Jordan Shin

Jordan Shin is a seasoned medical professional currently serving as Chief Medical Officer at HAYA Therapeutics since September 2024. Prior to this role, Jordan held the position of Senior Vice President of Clinical Development and Translational Science in Cardiology at LEXEO Therapeutics from January 2023 to May 2024, and was Senior Vice President at Renovacor from September 2021 to December 2022. Experience also includes a long tenure at Lung Biotechnology, Inc., where Jordan served as Vice President and Medical Director from September 2013 to September 2021. Earlier academic contributions include serving as Assistant Professor of Medicine and Instructor in Medicine at Harvard Medical School between July 2004 and September 2016. Jordan holds an AB from Harvard University and an MD, PhD from the University of Alabama School of Medicine.